The Peptide Landscape of 2026: Metabolic Dominance and the Rise of Specialized Bioregulators

Recent developments in peptide therapeutics highlight a transition from mass-market metabolic dominance toward specialized applications in tissue repair, mitochondrial health, and cognitive enhancement under increasingly stringent regulatory oversight.